These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 16374544

  • 1. Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin.
    Sánchez AM, Sánchez MG, Malagarie-Cazenave S, Olea N, Díaz-Laviada I.
    Apoptosis; 2006 Jan; 11(1):89-99. PubMed ID: 16374544
    [Abstract] [Full Text] [Related]

  • 2. Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells.
    Mori A, Lehmann S, O'Kelly J, Kumagai T, Desmond JC, Pervan M, McBride WH, Kizaki M, Koeffler HP.
    Cancer Res; 2006 Mar 15; 66(6):3222-9. PubMed ID: 16540674
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
    Chiu FL, Lin JK.
    Prostate; 2008 Jan 01; 68(1):61-71. PubMed ID: 18008333
    [Abstract] [Full Text] [Related]

  • 4. Phenethyl isothiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential.
    Xiao D, Lew KL, Zeng Y, Xiao H, Marynowski SW, Dhir R, Singh SV.
    Carcinogenesis; 2006 Nov 01; 27(11):2223-34. PubMed ID: 16774948
    [Abstract] [Full Text] [Related]

  • 5. The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts.
    Samsel L, Zaidel G, Drumgoole HM, Jelovac D, Drachenberg C, Rhee JG, Brodie AM, Bielawska A, Smyth MJ.
    Prostate; 2004 Mar 01; 58(4):382-93. PubMed ID: 14968439
    [Abstract] [Full Text] [Related]

  • 6. Capsaicin mediates cell death in bladder cancer T24 cells through reactive oxygen species production and mitochondrial depolarization.
    Yang ZH, Wang XH, Wang HP, Hu LQ, Zheng XM, Li SW.
    Urology; 2010 Mar 01; 75(3):735-41. PubMed ID: 19592070
    [Abstract] [Full Text] [Related]

  • 7. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F, Lee J, Lu S, Pettaway CA, Dong Z.
    Clin Cancer Res; 2005 Jun 15; 11(12):4512-20. PubMed ID: 15958637
    [Abstract] [Full Text] [Related]

  • 8. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
    Hellsten R, Johansson M, Dahlman A, Dizeyi N, Sterner O, Bjartell A.
    Prostate; 2008 Feb 15; 68(3):269-80. PubMed ID: 18163422
    [Abstract] [Full Text] [Related]

  • 9. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
    Suy S, Mitchell JB, Samuni A, Mueller S, Kasid U.
    Cancer; 2005 Mar 15; 103(6):1302-13. PubMed ID: 15685617
    [Abstract] [Full Text] [Related]

  • 10. Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells.
    Srinivasan S, Ranga RS, Burikhanov R, Han SS, Chendil D.
    Cancer Res; 2007 Jan 01; 67(1):246-53. PubMed ID: 17185378
    [Abstract] [Full Text] [Related]

  • 11. Establishment of human prostate tumor xenografts in nude mice and response to 9-nitrocamptothecin in vivo and in vitro does not correlate with the expression of various apoptosis-regulating proteins.
    Pantazis P, Chatterjee D, Wyche J, DeJesus A, Early J, Plaschke S, Giovanella B.
    J Exp Ther Oncol; 1996 Sep 01; 1(5):322-33. PubMed ID: 9414421
    [Abstract] [Full Text] [Related]

  • 12. Non-pungent capsaicinoids from sweet pepper synthesis and evaluation of the chemopreventive and anticancer potential.
    Macho A, Lucena C, Sancho R, Daddario N, Minassi A, Muñoz E, Appendino G.
    Eur J Nutr; 2003 Jan 01; 42(1):2-9. PubMed ID: 12594536
    [Abstract] [Full Text] [Related]

  • 13. GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancer.
    Narita S, So A, Ettinger S, Hayashi N, Muramaki M, Fazli L, Kim Y, Gleave ME.
    Clin Cancer Res; 2008 Sep 15; 14(18):5769-77. PubMed ID: 18794086
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
    Zhang Y, Ma Y, Lu HP, Gao JH, Liang CS, Liu CZ, Zou JT, Wang HQ.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2284-9. PubMed ID: 19080333
    [Abstract] [Full Text] [Related]

  • 15. Apoptotic effect of tolfenamic acid in androgen receptor-independent prostate cancer cell and xenograft tumor through specificity protein 1.
    Choi ES, Shim JH, Jung JY, Kim HJ, Choi KH, Shin JA, Nam JS, Cho NP, Cho SD.
    Cancer Sci; 2011 Apr 20; 102(4):742-8. PubMed ID: 21241418
    [Abstract] [Full Text] [Related]

  • 16. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
    Lu S, Lee J, Revelo M, Wang X, Lu S, Dong Z.
    Clin Cancer Res; 2007 Oct 01; 13(19):5692-702. PubMed ID: 17908958
    [Abstract] [Full Text] [Related]

  • 17. Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis.
    Kyprianou N, Benning CM.
    Cancer Res; 2000 Aug 15; 60(16):4550-5. PubMed ID: 10969806
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer.
    You Z, Shi XB, DuRaine G, Haudenschild D, Tepper CG, Lo SH, Gandour-Edwards R, de Vere White RW, Reddi AH.
    Cancer Res; 2006 Jan 01; 66(1):175-83. PubMed ID: 16397230
    [Abstract] [Full Text] [Related]

  • 19. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
    Lee SO, Yeon Chun J, Nadiminty N, Trump DL, Ip C, Dong Y, Gao AC.
    Prostate; 2006 Jul 01; 66(10):1070-5. PubMed ID: 16637076
    [Abstract] [Full Text] [Related]

  • 20. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts.
    Chen D, Cui QC, Yang H, Barrea RA, Sarkar FH, Sheng S, Yan B, Reddy GP, Dou QP.
    Cancer Res; 2007 Feb 15; 67(4):1636-44. PubMed ID: 17308104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.